Companies, investors, and shareholders have business imperatives to ensure boards reflect the populations that companies serve. Meanwhile, state policy, institutional investors, and proposed disclosure requirements have changed how companies approach representation on corporate boards. In this session, learn about resources to help you meet these objectives and hear about corporate governance approaches that support both diversity and innovation in biotechnology.